Castle Biosciences (CSTL) - מזומנים למניה

Castle Bio - לוגו גרפי של המנפיק CSTL

Castle Biosciences relies on the US domestic market, remaining sensitive to reagent supply disruptions. The cash per share trend, where the current value equals 8.96, links these risks to the expansion strategy for skin genetic tests. Meanwhile, financial stability is based on recognized melanoma diagnostic standards, although profitability is limited by fixed insurance reimbursement rates.

מזומנים למניה אחת castlebiosciences.com (CSTL): לתקופה 04.07.2022 - 20.11.2026

פילוחי מדדים מקיפים ואנליטיקה עבור Castle Bio (CSTL)

- שווי מניות ותחזית קונצנזוס למחירים:
- מדדי זמינות כספים ותזרימי מזומנים:
ניתוח כללי של החברה:Castle Biosciences Corp - CSTL
פריט של המותג Castle Biosciences Corp

To identify drivers of resilience, the investor analyzes the ratio of total liquid assets to the number of shares outstanding, as reflected in the change in cash per share. This indicator determines the internal margin of safety for Castle Biosciences (CSTL), allowing the company to mitigate the risks of shortages in imported reagents and chips should geopolitical disruptions occur within global supply chains.